• Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

  • 2024/07/01
  • 再生時間: 20 分
  • ポッドキャスト

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

  • サマリー

  • Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life.

    Read the article: https://lupus.bmj.com/content/11/1/e001114

    続きを読む 一部表示

あらすじ・解説

Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatology, University Hospitals of Strasbourg as they discuss systemic lupus erythematosus (SLE) clinical trials. In this episode, Dr. Arnaud highlights the complexities of drug approval processes in lupus, the pivotal role of large-scale phase three randomized trials and critical outcome measures in these trials, from primary endpoints assessing treatment efficacy to secondary and exploratory measures capturing broader impacts on patient health and quality of life.

Read the article: https://lupus.bmj.com/content/11/1/e001114

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Developmentに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。